Perrigo Company PLC (PRGO): Rasio rega marang dodolan
The average P/S of Perrigo Company plc (PRGO) demonstrates the impact of personnel stability among chemical technologists on cash flows, with the 0.60 mark reflecting the latest data. This trend is driven by trade barriers and logistical disruptions in global supply chains. Simultaneously, management is optimizing the corporate structure by divesting non-core assets to increase margins within the consumer healthcare sector.
%20Multiplikator%20P%2FS&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_PRGO_-_Perrigo-Company-plc_-_PS-Multiple "PRGO - Rega marang dodolan Perrigo Company plc ing rentang 04.07.2022 - 13.11.2026 | 👁️GURU.Markets👁️")
Rincian analitis perusahaan Perrigo Company (PRGO)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai aset resik miturut neraca:
- statistik kawajiban utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Perrigo Company plc|PRGO - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Perrigo Corp|PRGO - Gunggung utang perusahaan|Utang marang aset resik Perrigo Company|PRGO - Utang jangka dawa perusahaan|Utang jangka cendhak Perrigo|Rasio jangkoan perantara perrigo.com
- data bathi lan kelipatan valuasi:
PRGO - Bathi resik|Bathi mangsa ngarep Perrigo Company plc|PRGO - Rasio rega marang bathi|Rasio prakiraan rega marang bathi Perrigo Company PLC|PRGO - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Perrigo Company|PRGO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan Perrigo|PRGO - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan perrigo.com|PRGO - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Perrigo Company plc
- data total pendapatan lan volume dodolan:
Analisis umum perusahaan:Perrigo Company plc
The P/S multiple reflects the market value of a business relative to its generated revenue, allowing for the determination of asset overvaluation by comparing market capitalization with actual sales. By analyzing current P/S dynamics, an investor can identify undervaluation points for Perrigo Company plc (PRGO), where growth potential is supported by leadership in the store-brand pharmaceutical segment and the consumer shift toward affordable generic alternatives to brand-name drugs.
Pesaing Perrigo Company plc
HLN (haleon.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Kenvue KVUE|VRNA (Verona Pharma PLC) - Rasio rega marang dodolan|Jyong Biotech Corp - Multiplikator P/S|Rega marang dodolan Ligand Corp|Amneal Pharmaceuticals (AMRX) - Rasio rega marang pendapatan|alvotech.com - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Liquidia|GLPG: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ANIP|Koefisien rega marang pendapatan Afrezza|Multiplikator P/S AMPH (Amphastar Pharmaceuticals)|Multiplikator rega marang pendapatan pacira.com|SPRY - Rasio rega marang pendapatan|Rega marang dodolan Theravance Biopharma Inc|AQST (Aquestive Pharma) - Kapitalisasi marang pendapatan|scPharmaceuticals - Rasio kapitalisasi pasar marang pendapatan|TECX (Tectonic Therapeutic Inc.) - Multiplikator P/S|Kapitalisasi marang pendapatan tonixpharma.com (TNXP)|Rasio rega marang pendapatan China SXT Pharmaceuticals (SXTC)|EPRX - Rega marang dodolan|Rasio rega marang pendapatan BioHarvest BHST|EXOZ - Kapitalisasi marang pendapatan|ORMP - Rasio rega marang pendapatan|Rasio rega marang dodolan ENTX|HYFT: Multiplikator P/S|ABVC BioPharma Inc. (ABVC) - Multiplikator P/S|Rasio rega marang pendapatan Cumberland Pharma|Rasio kapitalisasi marang pendapatan QNTM (Quantum BioPharma Corp)|Kapitalisasi marang pendapatan FGEN (FibroGen, Inc.)|TELO - Rega marang dodolan|Rani Therapeutics Holdings, Inc. - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan SNYR|RLYB - Rasio rega marang pendapatan|Rasio rega marang dodolan LEXX|Pulmatrix, Inc. (PULM) - Rasio rega marang pendapatan|PTHL (Pheton Holdings) - Rasio rega marang pendapatan|APM (Aptorum Group Ltd) - Multiplikator P/S|Kapitalisasi marang pendapatan Lyra Therapeutics Inc. (LYRA)|Rasio rega marang pendapatan Impact BioMedical (IBO)|TNFA: Rasio rega marang dodolan|Rasio rega marang pendapatan cbdMD YCBD|Rasio kapitalisasi pasar marang pendapatan PRFX|Auris Medical - Multiplikator P/S|Multiplikator rega marang pendapatan Lipella Pharmaceuticals Inc (LIPO)|Optinose (OPTN) - Rasio rega marang pendapatan|Rega marang dodolan Pieris Pharma (PIRS)|Rasio rega marang pendapatan Procaps Group S.A.|petrospharma.com - Rasio rega marang dodolan|Multiplikator P/S QLI|SLRN (Acelyrin Inc.) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S TFFP (TFF Pharma)
